COVID-19: LEGAL IMPLICATIONS

The coronavirus crisis poses many questions.
We provide the answers.

Focusing on your interests

The current crisis in connection with the spread of the coronavirus is having a significant impact on the real economy as well as global financial markets and poses major challenges for the business activities of many companies in Germany. In order to counter the economic consequences, the European institutions

as well as the German authorities at the federal and state levels are taking economic and financial policy measures. Our multidisciplinary team of experts is at your disposal to assist with up‑to‑date information and comprehensive expertise on all legal issues to support you and your company in these challenging times. We focus on your goals and interests and are there for you when you need us.

COVID-19: Specific legal information

Corporate compliance in times of crisis

The corona pandemic is a stress test for business models and corporate governance structures as well as internal control systems (ICS) and compliance management systems (CMS) of almost all companies, regardless of their industry affiliation, size, age or legal form. How reliably can companies ensure that all applicable regulations are observed and abuses within the company are avoided in this unique situation? How can the company protect itself from suffering additional damage through external misconduct during the crisis? A consistently risk-based and effectively implemented CMS delivers an important overall contribution in crisis management situations to:

  • Company-wide coordinated analysis of and compliance with special regulations such as compliance with curfews and quarantine measures including reporting obligations under the German Infection Protection Act, prevention of the delayed filing of insolvency, subsidy fraud in connection with state aid, using emergency loans or tax relief as well as the associated documentation obligations and corresponding corporate and entrepreneurial liability
  • A risk management in accordance with Sections 91 II. and 93 AktG (Stock Corporation Act), 43 GmbHG (Law on Limited Liability Companies) or 34 GenG (Business Judgment Rule).
  • Decision-making competencies such as reviewing existing management and supervisory board statutes, decision catalogues and other corporate guidelines.
  • Communication obligations such as ad-hoc crisis communication as per EU MAR and WpHG (Securities Trading Act).
  • Auditing and documentation obligations in the fields of HR, supply chain compliance and data protection compliance.
  • Sustainable crisis communication for all employees in the sense of an effective “tone at the top”.
  • Special compliance risk analyses and compliance health checks to identify company divisions, functions or projects that are particularly susceptible to a crisis.
  • Target group-specific compliance training such as using e-learning and webinar formats especially in times of working from home and telework. 
  • A risk-based compliance set of rules involving third parties such as business partners and suppliers in the Code of Conduct.

Our GSK Stockmann Compliance team will support you in all crisis management matters and will also be happy to get you ready early on for the challenges of what will hopefully be a  fast recovery after the crisis.

Our expert publications
» Fight against COVID 19 fraud is new investigation priority of the US Department of Justice (24 March 2020)

Your contact
Eric Mayer
+49 89 288174-73
eric.mayer@gsk.de
View lawyer profile

The COVID-19 disease and its rapid spread lead to unprecedented challenges in the working environment. Many people have switched to working from home. The flood of applications for aid programmes set up at federal and state level poses a great challenge for the receiving agencies. Companies are adapting to the crisis-related circumstances. What all of these aspects have in common is the fact that they use digital solutions. This automatically puts data protection issues on the agenda.

The most frequently asked questions are currently:

  • Do we really have to think about data protection on top of everything else right now?
  • What are the particularities of data protection laws when working from home?
  • How can new solutions and applications for employees, customers, business partners and applicants be implemented quickly and in compliance with data protection regulations?
  • Are data analyses allowed to be carried out during the crisis to gain information and if so, what are the limits?

Our digital and data protection team at GSK Stockmann will be happy to answer all of these questions and more.

Our expert publications
» The home office from a data protection perspective in times of the coronavirus (20 March 2020)

Your contact
Katy Ritzmann
+49 30 203907-422
katy.ritzmann@gsk.de
View lawyer profile

Just as it affects the global economy, the coronavirus pandemic will also put a strain on existing and newly initiated contractual relationships. Contracting parties around the world are experiencing difficulties in fulfilling their contractual obligations. In uncertain times such as these, potential business partners tend to shy away from entering business relationships. At the same time, the exceptional economic situation is challenging legislators everywhere to temporarily amend laws which has a significant impact on existing and future contractual relationships.

No matter if you find yourself right before or in the middle of disputes resulting from the crisis – GSK Stockmann’s Dispute Resolution team will assist you in all matters relating to examining existing contracts, out‑of‑court contract adjustments, preparing and conducting settlement talks, mediation, and in court and (international) arbitration proceedings with business partners, insurance companies and, not least, the state. We apply the available legal instruments to enforce your interests. This refers in particular to the coronavirus‑related amendments to the Introductory Act to the German Civil Code (Einführungsgesetz zum Bürgerlichen Gesetzbuch) coming into force on 1 April 2020, as well as to currently relevant force majeure issues, hardship and MAC clauses, impossibility of performance, interference with the basis of the transaction and termination without notice.

The same applies to newly initiated business relationships. In times of crisis, they should be all the more so founded on a firm basis in order to be successful. To this end, GSK Stockmann’s Dispute Resolution team offers comprehensive advice on contract design, takes into account the risks the pandemic holds for the economy and individual businesses and includes tailor‑made conflict resolution clauses that anticipate future developments.

Our expert publications
» Securing payment transactions in international trade (07 May 2020)
» Arbitral proceedings – efficient and effective during times of COVID-19? (17 April 2020)
» Sanity Check for Your Contracts – New ICC Force Majeure and Hardship Model Clauses (07 April 2020)
» Impact of the coronavirus pandemic on contractual relationships (30 March 2020)

Your contact
Justus Jansen
+49 40 369703-62
justus.jansen@gsk.de
View lawyer profile

The current coronavirus pandemic is increasingly impacting a whole range of aspects of our lives. In their role as employers, companies are affected in several ways and must find answers to important employment law questions and take appropriate measures concerning their workforce:

  • Which precautions can or must an employer take to protect employees or to maintain operations?
  • What types of leave are there and how do they affect an employee’s remuneration entitlements?  
  • What is the procedure if an employee needs to take care of relatives?
  • What happens in case of official orders or quarantine?
  • What are the options for working from home and what are important points to consider when implementing them?

In this difficult economic situation, employers are also confronted with urgent questions regarding financial relief options as well as more fundamental questions regarding the continuation of employment relationships:

  • Is it possible to defer social security payments?
  • Can employers resort to short-time work and apply for short-time allowances to bridge a period of lack of work and what are the requirements for that?
  • What are potential pitfalls to consider if dismissals due to operational reasons cannot be avoided in the current situation?

The Employment team at GSK Stockmann is at your disposal at all times to answer these and other questions and to provide concrete recommendations for implementing specific employment law measures.

Our expert publications
» Working during the coronavirus pandemic: As an employer, how do I deal with employees returning from holidays? (01. September 2020)
» Employment law issues in connection with the coronavirus (13 March 2020) (in German)

Your contact
Wolfgang Böhm
+49 6221 4566-0
wolfgang.boehm@gsk.de
View lawyer profile

Since mid-March, the German government has announced or launched comprehensive aid packages to mitigate the impact of the coronavirus pandemic on companies and on the labour market. Through the “protective shield” for the economy worth billions of euros, the Federal Ministry of Economics wants to provide fast and unbureaucratic help to small and medium-sized companies, corporations, one-person businesses and freelancers. Since the individual federal states are also active in this respect, new aid and relief measures appear constantly.

Programmes at the federal level:

  • Protective shield for businesses and companies
  • Easier access to loans from the state-owned Kreditanstalt für Wiederaufbau (KfW)
  • Easier access to bank guarantees
  • KfW Special Programme 2020
  • Tax liquidity relief
  • Economic Stabilisation Fund
  • Aid package for start-ups
  • KfW instant loan for SMEs
  • Emergency aid package for micro-enterprises, one-person businesses and freelancers
  • “Go-digital” support measures for SMEs

Programmes at state level:

  • Bavaria
  • Hesse
  • Other federal states

Our team at GSK Stockmann is ready to answer any questions you may have and will keep you up to date consistently about aid and relief programmes at federal, state and EU level. Please also refer to our overall presentation on state aid available during the coronavirus pandemic. Upon request, we can provide you with a summary of current developments and measures at federal, state and EU level, update it regularly and advise you as needed.

Our expert publications
» Corporate financing in times of the corona-virus – available government programmes (09 April 2020)

Your contact
Katy Ritzmann
+49 30 203907-422
katy.ritzmann@gsk.de
View lawyer profile

The financial, funds and capital markets sectors are not shielded against the coronavirus pandemic and its effects. Thus, law makers and supervisory authorities in Germany and at the EU – above all ESMA and BaFin – are trying to ensure financial (market) stability and to back up markets and financial market participants.

In addition to adjusting some supervisory requirements, for instance in connection with the MiFID II requirements, trading activities and short‑selling bans, as well as modifications to the requirements for capital bases, legislators and supervisory authorities are paying particular attention to lending activities and possible loan defaults, such as:

  • Debt moratoria
  • Required information on particular credit risks
  • Civil law modifications in the context of consumer loan repayment and the exclusion of termination due to rent arrears

Funds are also affected:

  • Risk warnings in sales prospectuses are being expanded.
  • Real assets can no longer be easily valued on site.
  • Supervisory authorities are currently closely monitoring investor redemption behaviour, particularly in mutual funds.

The focus is currently on existing emergency and restructuring plans in regulated units – topics that are not normally of such high interest. Thus, regulatory legislation that moves quickly even in normal times, has seen an additional increase in speed since the beginning of March. Now, changes and reactions are published almost on a daily basis, and many publications also contain facilitation measures for the sector as a whole.

Our team at GSK Stockmann continuously monitors the numerous legal and regulatory changes. We are familiar with the various options available to you and we are happy to support you in developing concrete solutions and deriving appropriate decisions for your company. Please do not hesitate to contact us.

Finance
Alma Franke
+49 89 288174-667
alma.franke@gsk.de
View lawyer profile

Financial Regulation
Philippe Lorenz
+49 89 288174-662
philippe.lorenz@gsk.de
View lawyer profile

The coronavirus pandemic has considerable effects on private building and architect law and raises a multitude of (legal) questions and problems in day-to-day practice, for instance, in the context of

  • coronavirus-related disruptions in the building process,
  • extension of execution deadlines,
  • claims for compensation and/or damages,
  • the termination of contracts as well as safety and hygiene on construction sites.

There certainly are laws regulating these issues, such as Sec. 313 BGB (German Civil Code) regarding the loss of the basis of a contract, Sec. 6 of the VOB/B (Regulations on Contract Awards for Public Works part B) on the obstruction of construction work, etc. However, the concrete application of these regulations to the legal effects of the coronavirus pandemic is still largely uncharted territory.

Due to official measures in the course of the coronavirus pandemic and its continued dynamic development, construction processes may be disrupted, in some cases considerably, and even the closure of construction sites cannot be ruled out at present. Entry bans and border controls or border closures can cause a shortage of available workers. Domestic and international production shutdowns and restrictions can cause considerable supply bottlenecks and material shortages. Social distancing rules and quarantine measures sometimes severely restrict the construction process and progress. The associated occupational safety and health measures and requirements place high demands on construction site operators: risk assessments and safety and health protection plans must be continuously updated, the applicable contact restrictions and hygiene recommendations must be implemented through appropriate measures, etc.

For the legal assessment of coronavirus-related disruptions of the construction process, it is deci-sive whether they are due to a case of force majeure. According to a decree issued by the Federal Ministry of the Interior, Building and Community on 23 March 2020, the coronavirus pandemic is in principle suitable to constitute a case of force majeure. Although this decree only applies to federal construction projects, its content can be used as a general guideline. However, each case will have to be assessed individually for a definite conclusion.

On 11 March 2020, the World Health Organization (WHO) declared the coronavirus epidemic a pandemic. In particular in the context of newly concluded building and architects’ contracts, this raises the question whether coronavirus-related effects can be regarded as force majeure even after this date. In this case, it is probably advisable, both from the point of view of the contractor and the client, to include highly precautionary so-called “coronavirus clauses” in newly drafted contracts. Such clauses are currently being intensively discussed in the construction industry.

The team at GSK Stockmann stands ready to answer all your questions and advise you on all matters relating to the coronavirus pandemic and its effects.

Your contact
Prof. Dr. Oliver Moufang
+49 69 71003-147
oliver.moufang@gsk.de
View lawyer profile

Urgent procurement needs, bans on assembly and social distancing orders as well as quarantines disrupt the normal course of award procedures. Are direct awards allowed? Can deadlines be shortened or rather extended? How should appointments be conducted that normally require personal attendance such as negotiations?

COVID-19-related emergency procurement

On 19 March 2020, the German Federal Ministry for Economics (BMWi) sent out a bulletin, stating that in the context of procurements required at short notice in order to contain and overcome the coronavirus epidemic, urgent reasons may be able to justify negotiation procedures/awards procedures without competitive tendering (BMWi bulletin (in German) tinyurl.com/BMWi-Corona).

In addition, the BMWi now allows contractual amendments such as an increase in delivery volumes and the extension of contracts under Sec. 132 (2)(1)(3) of the Law against Restraints of Competition (GWB). However, a 50% limit applies for the increase of the order value.

Impact on all other procurements

  • In principle, negotiations may be held as telephone and video conferences; Sections 9 ff. of the Regulation on the Award of Public Contracts (VgV) must be observed.
  • We recommend granting appropriate extensions requested by bidders.
  • Procedures without competitive tendering remain permissible only under the existing strict conditions.
  • In view of the current situation, contractual amendments may be permissible in individual cases.
  • In order to avoid the insolvency of a contractor and re‑tendering, advance payments should be considered as long as they are in line with budgetary law.

It remains to be seen whether, in view of the corona crisis, the economic stimulus packages released in the wake of the financial crisis will be relaunched. In the long term, it can be expected that the public sector will regain importance as a buyer of services and that the time of award procedures with few or no bids is coming to an end.

Our Procurement team at GSK Stockmann is happy to assist you in overcoming coronavirus‑related challenges in your procurement processes.

Our expert publications
» Coronavirus: first public procurement and state aid considerations on the current crisis (13 March 2020) (in German)

Your contact
Jenny Mehlitz
+49 30 203907-7766
jenny.mehlitz@gsk.de
View lawyer profile

Government measures to prevent the spread of COVID-19

Since the outbreak of the coronavirus pandemic, a large number of government measures based on the German Infection Control Act have been issued through general rulings or ordinances at municipal or state level. In order to slow the spread of the virus measures such as operating bans, bans on opening shops or offering services greatly impact commercial businesses. Additionally, measures targeting the civilian population such as entry checks and border control are bound to affect businesses as well:

  • Government measures that include operating restrictions or bans directly target the use of commercial enterprises – in real estate, therefore, this regularly affects the tenants, not the landlords.
  • For businesses, state subsidies are intended to mitigate financial losses.
  • In addition, in order to protect tenants, the German government has suspended the landlord’s termination options in the event of late payment, if the tenant can credibly demonstrate that the delay in payment is due to the pandemic.
  • However, it is still unclear whether tenants or landlords can make compensation claims for this against the state. The situation really calls for a simple legal basis for compensation claims as provided by the Infection Protection Act for employees and self‑employed persons and in the police laws of the federal states. The applicability of the rules must be examined on a case‑by‑case basis. Judicially developed claims for compensation for “special sacrifices” (Sonderopfer) will generally not apply to tenants and landlords.

Curfews and social distancing orders can impact planning and approval procedures involving public participation: Stakeholders must consider postponing public participation procedures or extending public presentation. The Public team at GSK Stockmann is closely monitoring the development and is at your disposal to answer questions regarding the scope of these bans, possible compensations as well as on their implications on planning and approval procedures.

Our expert publications
» COVID-19: the European Commission’s Temporary Framework to support the economy from (20 March 2020) (in German)
» Coronavirus: first public procurement and state aid considerations on the current crisis (13 March 2020) (in German)

Your contact
Kristina Marx
+49 30 203907-81
kristina.marx@gsk.de
View lawyer profile

Many tenants are currently facing great financial difficulties. Hotels are particularly affected but the entire retail & leisure sector is also suffering from state-issued restrictions or was even forced to close down completely – with the exception of a few privileged stores. However, office or residential tenants may also be confronted with financial difficulties if they belong to a sector that is particularly affected by the pandemic and therefore have to contend with a significant drop in sales or loss of income.

The law to cushion the impacts of the coronavirus pandemic in civil law, insolvency law and criminal procedural law of 27 March 2020 (“COVID-19 Act”) was a first step to protect commercial tenants who are unable to pay their rent as a result of the pandemic and are therefore in danger of losing their rental space and thus their livelihood. It is a widespread misconception that this COVID-19 Act grants any tenant a deferral of rent payments for the period April to June 2020, i.e. that any tenant can just not pay rent for this time. That, however, is not true. Tenants who cannot pay their rent for the months April to June 2020 due to the pandemic cannot be terminated. Landlords will only be able to terminate such tenants’ lease agreements if the tenant still has not paid the rent by June 2022. Irrespective of this, however, tenants remain obliged to pay the rent and they owe default interest when they don’t. The statutory default interest rate for commercial tenants is 9 percentage points above the base rate and thus represents a heavy additional burden. As the rent becomes due, the tenant can also be sued for payment, has to fear enforcement measures and the potential realisation of rent securities. Ultimately, the COVID-19 Act does not protect just any tenant against termination, but only those who face hardship as a result of the pandemic and can credibly prove this. That doe snot apply to every tenant. At GSK Stockmann, we keep our clients up–to–date as the legal situation evolves.

The COVID-19 Act thus regulates only a protection against termination for affected tenants. However, most questions remain unanswered and new questions have been added by the COVID-19 Act:

  • What does the COVID-19 Act mean for me?
  • Can I reduce rent payments due to the effects of the coronavirus pandemic?
  • Can one party to a lease agreement withdraw form it due to the effects of the coronavirus pandemic?
  • What are points to consider if the landlord makes concessions to the tenant (e.g., in cases of financed real estate, landlords with supervisory restrictions, existing tenant easements, with regard to the written form requirement of Sec. 550 BGB, to avoid the risk of rescission under insolvency law, etc.)?
  • What are the options if landlords themselves face difficulties due to a lapse in rent payments?
  • What happens if completion or handover dates cannot be met due to the consequences of the pandemic?

Our Real Estate Asset Management team at GSK Stockmann will be happy to answer these and other questions arising in the context of dealing with the coronavirus crisis and its effects.

Your contact
Monique Franke
+49 89 288174-661
monique.franke@gsk.de
View lawyer profile

Many owners and investors are struggling with the question whether and how to sell and buy real estate in the current situation. Another major challenge besides financing is valuing the property and securing the cash flow required by most buyers once the transfer of economic ownership is complete. Finally, the issue of the tenants’ ability to pay currently also needs to be completely re-evaluated. Forward deals must be structured in a way that offers sufficient flexibility to accommodate for the uncertain effects of COVID-19. However, the market environment may also offer unprecedented investment opportunities. Considering the turbulences on other investment markets, investing in sustainable real estate in good locations can make sense. Against this background, drafting purchase agreements for real estate currently raises a few new questions:

  • Which stipulations should be included to allow for sufficient flexibility in finding the necessary financing?
  • How can a forward deal provide sufficient flexibility with regard to delays and other effects resulting from COVID-19?
  • What are useful clauses to handle uncertainties regarding the tenant (insolvency risk, substitute tenants, rental guarantees, etc.)?

Our team at GSK Stockmann will be happy to support you in preparing and assisting such sales/purchase processes.

Your contact
Dirk Brückner
+49 89 288174-71
dirk.brueckner@gsk.de
View lawyer profile

The coronavirus causes many companies existential hardship. Sales are breaking down. Fixed costs cannot be reduced quickly. The strict German rules on management liability in insolvency situations and the punishable obligation to file for insolvency are forcing many managers and shareholders to act. At the same time, many business partners of companies in distress, such as banks, landlords or suppliers, are wondering whether they can defer receivables, grant payment accommodations or provide new liquidity without risking revocatory action later. The legislator is attempting to reduce insolvency risks and facilitate liquidity at several levels.

The following questions are currently the most pressing:

As an operative company:

  • Do I have to file for insolvency? How does the new law help me?
  • How can liquidity be secured or strengthened in the short term?
  • What legal measures can I take in the short term to reduce fixed costs?

As supplier/landlord or other creditor:

  • Do I still have to deliver in order to fulfil my contractual obligations?
  • Do customers have to accept deliveries or may they cancel?
  • Can I grant deferrals or payments by instalments?
  • Can I grant a supplier loan?
  • Can I terminate contracts if the customer does not comply with them?

From a banking perspective:

  • Can banks grant financial aid in an bureaucratic manner or do they still have to observe the minimum supervisory requirements for risk management (MaRisk)?
  • What is the effect of repayment suspensions on the risk exposure and are they associated with stricter equity coverage requirements?
  • Apart from the classic loan, what other possibilities are available for supporting distressed customers?

Our Restructuring and Insolvency team at GSK Stockmann will be happy to answer these and all other restructuring questions in the context of the the coronavirus crisis.

Our expert publications
» Corporate financing in times of the corona-virus – available government programmes (09 April 2020)
» German lawmakers suspend obligation to file for insolvency (25 March 2020)
» The antidote – legislator will suspend the obligation to file for insolvency (17 March 2020)

Your contact
Andreas Dimmling
+49 89 288174-73
andreas.dimmling@gsk.de
View lawyer profile

State aid for companies

Since 12 March 2020, the European Commission has been rapidly putting in place rules and creating a decision-making practice to enable the Member States of the European Union to counter the consequences of the COVID-19 crisis and at the same time save the single market. These are the rules under which Member States and their public authorities will provide financial support to businesses. In the meantime, this has led to the creation of the main German programmes under which the Kreditanstalt für Wiederaufbau (KfW, German government-owned development bank) and now also the federal states’ development banks will be allowed to grant state aid to companies from 23 March 2020 onward.

This practice and general state aid law requirements provide answers and solutions to the following questions:

  • How can the public authorities grant state aid to businesses?
  • How can government companies contribute to helping their tenants, leaseholders and contractors in this crisis in accordance with state aid law?
  • What are the opportunities provided by the European Commission’s Temporary Framework to support the economy from 19 March 2020? What options does the extension of the Temporary Framework of 3 April 2020 offer, in particular in the context of aid for research and development, the construction and expansion of testing and upscaling facilities and manufacturing products (drugs, medical devices, raw materials, equipment, etc.) to be used against COVID-19? Following the second extension of the Temporary Framework of 8 May 2020, what are the requirements for state-funded recapitalisation measures and aid provided in the form of subordinated debt?
  • What assistance has been provided under the state aid programmes that have been approved until now by the European Commission (“Special Programme 2020 for Investments and Equipment Financing”), “Federal Guarantee Scheme 2020”, “Federal Small Grants Scheme 2020”, “Federal Loan Scheme”?
  • If the approved KfW programmes cannot be applied, can authorities grant other aid?
  • How far are the other EU Member States and the UK in their state aid programmes?
  • What are the consequences if aid needed to be granted quickly in order to help a company in a situation when state aid requirements could not be fulfilled?

Protecting the Single Market against competitive disotrtion and national egotism is particularly important during the COVID crisis. We assist you in utilizing state support for your company while at the same time complying with the requirements of state aid law. Our team at GSK Stockmann supports the public sector in designing state aid regulations and subsidies in line with state aid law, in (pre‑)notification contacts with the European Commission, in preliminary examination procedures and in state aid‑related litigation. We also advise companies on how to obtain state support in accordance with state aid law. Please do not hesitate to contact us!

Our expert publications
» Corporate financing in times of the corona-virus – available government programmes (09 April 2020)
» COVID-19: the European Commission’s Temporary Framework to support the economy from (20 March 2020) (in German)
» Coronavirus: First public procurement and state aid considerations on the current crisis (13 March 2020) (in German)

Your contact
Arne Gniechwitz
+49 40 369703-0
arne.gniechwitz@gsk.de
View lawyer profile

The social distancing restrictions and assembly bans associated with the COVID-19 pandemic are major challenges for any company’s ability to act. While in-person meetings of decision-making bodies (e.g., supervisory board, shareholders’ meetings or general meetings) are limited, companies must still be able to adopt resolutions (e.g., on the allocation of profits or the annual financial statements). The many challenges in this context raise the following and more questions:

  • How can the different bodies take decisions without being able to meet in person?
  • What do social distancing rules and assembly bans mean for general meetings of stock corporations this year?
  • Can they be held later than prescribed by the statutory period (eight months within the financial year)?

The legislator has recognised these problems and responded with the Act to Mitigate the Consequences of the COVID-19 Pandemic under Civil, Insolvency and Criminal Procedure Law from 27 March 2020 (COVID-19 Act).

Among other things, it allows stock corporations to hold their general meetings virtually this year without the physical presence of shareholders or their proxies if certain requirements are met. In addition, the COVID-19 Act contains the following derogations from the Stock Corporation Act (AktG):

  • Reduced notice period for convening general meetings
  • Extended deadline for holding general meetings
  • Limited actions for avoidance

Regarding company law, the COVID-19 Act allows all shareholder resolutions to be passed in text form or by written submission of votes even without the consent of all shareholders. Our GSK Stockmann team will be happy to assist you with all questions regarding virtual general meetings (from convening the meeting to minimising the risk of avoidance actions). You are also welcome to contact us for assistance in the context of holding shareholders’ meetings or passing resolutions in your company (GmbH law).

Our expert publications
» Coronavirus crisis: legislator allows virtual general meeting for stock corporations (07 April 2020) (in German)

Your contact
Jennifer Bierly
+49 30 203907-50
jennifer.bierly@gsk.de
View lawyer profile

Tax relief measures

Many companies are in economic distress because of the coronavirus pandemic. Tax payments for profitable past years will soon be due. Additionally, prepayments for future tax periods are now mostly set too high, as they are based on a much better income situation before the outbreak of the crisis. In order to ensure that such tax payments do not lead to insolvency or liquidity problems, the German Federal Ministry of Finance and the highest tax authorities of the federal states have now announced relief (ministry letter and identical state‑level decree from 19 March 2020):

  • Any affected companies can now apply for interest‑free tax deferrals, reductions of their tax prepayments and a suspension of enforcement measures. For now, the relief measures are in force until 31 December 2020.
  • The authorities have been instructed to not impose strict conditions for providing the relevant evidence.
  • Affected companies should react quickly and not hesitate to file the respective applications. Even if a company is not technically covered by the new measures, an application referencing the general rules and undue hardship can be promising, especially considering that the full economic impact of the coronavirus crisis is not yet foreseeable. Irrespective of this, companies should examine whether further tax relief through other measures (e.g. restructuring, loan waivers) would be helpful.

Our Tax team is at your disposal for further information and any questions you may have.

Our expert publications
» COVID-19 – Inheritance and gift tax relief (14 May 2020)
» COVID-19 – Further profits tax relief (07 May 2020)
» COVID-19 – Tax Relief for Investment Funds (17 April 2020)
» COVID-19 – VAT relief (15 April 2020)
» Corporate financing in times of the corona-virus – available government programmes (09 April 2020)
» COVID-19 – Tax Relief Measures (23 March 2020)

Your contact
Petra Eckl
+49 69 710003-0
petra.eckl@gsk.de
View lawyer profile

  • GSK Updates
    01 September 2020

    Working during the coronavirus pandemic: As an employer, how do I deal with employees returning from holidays?

    How does a trip to an area where there is a heightened risk affect the employment relationship?

    Read more
  • GSK Updates
    03 July 2020

    What employers need to know about the Corona Warning App

    What do employers have to consider from an employment law perspective when using the “Corona-Warn-App”?

    Read more
  • GSK Updates
    19 June 2020

    Corona Matching Facility and package of measures for start-ups and SMEs

    After a long waiting period, the 2 billion-euro package of measures has now been implemented in both pillars. The measures have been designed to provide financial support for innov...

    Read more

© GSK Stockmann 2020

* Partner: A partner within the meaning of the partnership company law.
   Local Partner: not a partner within the meaning of the partnership company law.
CO2 Neutral